NIH Common Fund Data Ecosystem (CFDE) FAIR Rubric
A rubric for evaluating the FAIRness of NIH-CFDE Resources
Tags: nihcommonfund
URL(s):
View AssociationsRubric Assessments (626384)
| Assessment | Metrics | Date | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Target | Project | Contact information is provided for the creator(s) of the dataset. | Globally unique identifier | Machine-readable metadata | Standardized metadata | Resource identifier in metadata | Open, Free, Standardized Access protocol | Digital resource license | Metadata license | NIH program name is available for querying | NIH project name is available for querying | The institution that created this dataset is available | A biological assay is present and resolvable in CFDE-specified ontology (OBI) | A relevant anatomical part is present and resolvable in the UBERON Ontology | A relevant disease is present and resolvable in the MONDO Ontology | A relevant file type is present and resolvable in the EDAM Ontology | A relevant taxonomy is present and resolvable in the NCBITaxon Ontology | A relevant cell line is present and resolvable in the Cellosaurus Ontology | A landing page exists and is accessible | ||
| Comprehensive analysis of transcriptome and metabolome in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Amino Acid levels in preB cells under starvation | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Zebrafish Metabolomics: Model for Environmental Metal Toxicity | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Quantitative measurements of amino acids in T1D poor control, good control, and controls. | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Replication study: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Relative level of inosine/adenosine and sarcosine | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Neuromodulator Metabolites of Dietary Salt Effects on Blood Pressure in Human Urine from DASH2 Clinical Trial (part IX) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Metabolme analysis of OPC-163493 on the Liver of ZDF rats (part-II) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Metabolite changes in human plasma before and after YF17D vaccination in symptomatic and asymptomatic subjects | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Non targeted metabolomic analysis of mouse and human bronchoalveolar lavage fluid, Aqueous(+) experiment (part I) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| C2C12 stretch cessation models muscle atrophy and anaplerotic changes in metabolism | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Global metabolomics of human milk fractions | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Metabolomics Analysis of Frontal Fibrosing Alopecia | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Metabolic Microenvironments in Normal Breast and Breast Cancer (NMR analysis) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | no (0.00) | yes (1.00) | yesbut (0.75) | no (0.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | Sep 23, 2019 | |
| Cardiac Resynchronization Therapy Induces Adaptive Metabolic Transitions in the Metabolomic Profile of Heart Failure | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Small cell lung cancer metabolome (part I) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | no (0.00) | yes (1.00) | yesbut (0.75) | no (0.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | Sep 23, 2019 | |
| NMR Metabolomics of Newborn Heart Tissue Exposed to Excess Maternal Cortisol in Late Gestation - Maternal (part -IV) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Bone Marrow Metabolomics (part I) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| metabolome in a group of AA and EA matched pairs of prostate cancer (PCa) and benign adjacent tissues | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Brain-Immune system-Gut Interaction in Chronic Mild Stress (CMS +/- Lacto) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography High-Resolution Mass Spectrometry Platforms (part IX) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Targeted Sphingolipids in Kallikrein 6 Mice after SCI | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | no (0.00) | yes (1.00) | yesbut (0.75) | no (0.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | Sep 23, 2019 | |
| Metabolomics profile of umbilical cord blood is associated with maternal pre-pregnant obesity in a perspective multi-ethnic cohort displaying health disparities | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Insights into the pathogenesis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) through metabolomic profiling of cerebrospinal fluid (part III) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | no (0.00) | yes (1.00) | yesbut (0.75) | no (0.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | Sep 23, 2019 | |
| Effects of NO Donor Therapy on the Dystrophic Mouse Muscle Non-Esterified Fatty Acids (part V) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
